Will the future of pharmacovigilance be more automated?
Francesco SalvoJoelle MicallefAmir LahouegueLaurent ChouchanaLouis LétinierJean-Luc FaillieAntoine ParientePublished in: Expert opinion on drug safety (2023)
The use of AI and IA tools will assist a large spectrum of PV activities, both in public and private PV systems, in particular for tasks of low added value (e.g. initial quality check, verification of essential regulatory information, search for duplicates). Testing, validating, and integrating these tools in the PV routine are the actual challenges for modern PV systems, to guarantee high-quality standards in terms of case management and signal detection.